The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. Photo by Martin Sanchez on Unsplash Merck ...
Molnupiravir was initially heralded by public-health officials as a game-changer for COVID-19, but full clinical-trial data showed lower-than-expected efficacy. Molnupiravir, one of two antiviral ...
BENGALURU, Oct 8 (Reuters) - Two Indian drugmakers have requested permission to end late-stage trials of their generic versions of Merck & Co's (MRK.N), opens new tab promising experimental oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback